Updates on BTK- and Bcl-2–targeted treatment in various B-cell malignancies
Updates on BTK- and Bcl-2–targeted treatment in variou
DLBCL: treatment of elderly patients and relapsed disease
DLBCL: treatment of elderly patients and relapsed dise
Waldenström macroglobulinemia: findings from ASPEN and BRUIN
Waldenström macroglobulinemia: findings from ASPEN and
Outcome improvements in relapsed and untreated marginal zone lymphoma
Outcome improvements in relapsed and untreated margina
Follicular lymphoma: study results with bispecific antibodies and BTK inhibitors
Follicular lymphoma: study results with bispecific ant
Current insights into BTK inhibition and other targeted approaches in CLL
Current insights into BTK inhibition and other targete
Preface – ASCO/EHA/ICML 2023
Preface – ASCO/EHA/ICML 2023 © Dirk Gillissen – Ar
Tackling acute myeloid leukemia via diverse pathways
Tackling acute myeloid leukemia via diverse path
New options in untreated and pretreated mantle cell lymphoma
New options in untreated and pretreated mantle c
Prolonging remission in relapsed and refractory follicular lymphoma
Prolonging remission in relapsed and refractory
